The invention provides methods and combination therapies for treating and/or preventing and/or slowing the onset and/or development of Alzheimers disease using a hydrogenated pyrido (4,3-b) indole (e.g., dimebon) in conjunction with another compound, pharmaceutically acceptable salt thereof or therapy for Alzheimers disease.